Golumbeski George 4
4 · Sage Therapeutics, Inc. · Filed May 9, 2022
Insider Transaction Report
Form 4
Golumbeski George
Director
Transactions
- Purchase
Common Stock
2022-05-05$31.45/sh+8,000$251,563→ 8,000 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $31.33 USD to $31.50 USD. The price reported above reflects the weighted average sale price. The issuer hereby undertakes to provide, upon request, to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.